RxDoctor Payments Data

Fumiko Hattori

Psychiatric/Mental Health · Paducah, KYNPI 1396154480

Payments from drug & device makers

$1,175in general payments, 2019–2025

Across 63 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$252
  • Otsuka America Pharmaceutical, Inc.$163
  • Johnson & Johnson$141
  • Alkermes, Inc.$121
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$94
  • Lundbeck LLC$75
  • plus $330 from 11 others

What the payments were for

  • Food & beverage$1,14798%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,175 in reported general payments places this provider in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$23,826
Medicare patients
88
Services billed
345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate132$461,296
VraylarCariprazine Hcl164$177,308
AustedoDeutetrabenazine30$145,390
RexultiBrexpiprazole70$98,917
Abilify MaintenaAripiprazole31$89,326
Austedo XrDeutetrabenazine11$80,675
Aripiprazole211$36,840
TrintellixVortioxetine Hydrobromide65$35,493
FanaptIloperidone11$35,367
Paliperidone ErPaliperidone70$20,602
Asenapine Maleate62$16,016
Seroquel XrQuetiapine Fumarate12$15,858
Lurasidone Hcl134$15,609
Quetiapine Fumarate571$13,225
Olanzapine198$8,529

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$141$461,296132 claims
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$21$226,06541 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$163$188,243101 claims
AbbVieVraylar$252$177,308164 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$19$35,49365 claims
Vanda Pharmaceuticals Inc.Fanapt$57$35,36711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Paducah

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →